Natco Pharma surges 20%, hits new high on USFDA nod for cancer drug
The company has received approval from the US health regulator for the generic version of Celgene's multiple myeloma drug, Revlimid (Lenalidomide) capsules in the US
The company has received approval from the US health regulator for the generic version of Celgene's multiple myeloma drug, Revlimid (Lenalidomide) capsules in the US https://ift.tt/3unWP7H May 23, 2021 at 06:30PM
The company has received approval from the US health regulator for the generic version of Celgene's multiple myeloma drug, Revlimid (Lenalidomide) capsules in the US https://ift.tt/3unWP7H May 23, 2021 at 06:30PM
Comments
Post a Comment